August 26, 2015 - Read the full Forbes article and watch the interview here: http://onforb.es/1hXj6Ej. Subscribe to this podcast on iTunes by clicking here: http://bit.ly/ymotwitunes or on Stitcher by clicking here: http://bit.ly/ymotwstitcher. This one is personal. I apologize now, but understand that I simply can’t be entirely objective about type 1 diabetes or T1D. My wife has had diabetes for over fifty years and my son has had it for nearly two decades. Improved treatments have largely spared my son the sorts of debilitating consequences my wife has experienced, but hasn’t spared him from multiple daily injections, finger pricks, and the cumbersome tethers of insulin pumps and glucose monitors. Derek Rapp, the CEO of JDRF, says that the organization dedicated to finding a cure for T1D is making progress. Like me, he says, “JDRF was created—and is still led—by people with a personal connection to type 1 diabetes.” Rapp adds, “It’s an exciting time for type 1 diabetes research, JDRF is on the verge of life changing breakthroughs that will fundamentally improve the way people live with type 1 diabetes. This progress isn’t by accident and, in fact, it directly reflects the vision, focus and investments of JDRF over the last decade.” “Our work has led to new treatments for diabetic eye disease, the creation of first-generation artificial pancreas systems, and the first human clinical trial of encapsulated cell-replacement therapies that have the potential to replace insulin treatment,” he continues. “Every dollar we direct toward our mission comes from our supporters and donors, who enable us to make real progress and propel us toward our goal of a world without type 1 diabetes,” he concludes. Please consider whether a friend or colleague might benefit from this piece and, if so, share it.
#286: JDRF Is All About The Cure